Epilepsy Therapeutic Market by Product Type - Global Industry Analysis and Forecast to 2023

Published On : February 2018 Pages : 80 Category: Medical Devices Report Code : HC02560

Industry Outlook and Trend Analysis

The Epilepsy Therapeutic Market has observed considerable development in the recent years and is foreseen to encounter tremendous development in the upcoming years due to the rising prevalence of epilepsy. The high neglected therapeutic need will drive the development prospects for the market throughout the estimate time frame. The absence of any disease changing treatment is driving the rate of neglected medical need in the epilepsy therapeutics market. The medications managed to treat epilepsy help suppress symptoms, for example, seizures and give substantial help to people. Nonetheless, these treatments or medicines fail to avert the progression of this infection and reverse the acquired neuronal damage.

Product type Outlook and Trend Analysis

The first-generation antiepileptic drugs (AEDs) fragment incorporates valproic acid, benzodiazepines, carbamazepine, phenobarbital, and phenytoin. This fragment represented the biggest share of the market in 2017 because of its first-mover advantage and high rate adoption in the market. Medications, for example, Dilantin and Tegretol are used to prevent seizures by hindering the voltage-dependent sodium channels and forestalling high-recurrence dull neuronal firing.

Regional Outlook and Trend Analysis

Geographically, the epilepsy restorative therapeutic in APAC will develop at a significant CAGR amid the conjecture time frame. The high neglected medicinal need in the locale will drive the development prospects for the market over the forecast period. The absence of any ailment changing treatment is driving the rate of neglected restorative need in the epilepsy therapeutics market in APAC.

Competitive Insights

The epilepsy therapeutics market is defined by the existence of a many mid-sized and small players and is profoundly competitive. These players are progressively going up against each other in light of the reformulation of as of now marketed medication to expand their patent protection. The leading players in the market are Janssen Pharmaceutica NV, GlaxoSmithKline, Eisai, Dainippon Sumitomo Pharma Co Ltd, Benetton Group and Pfizer.

The Epilepsy Therapeutic Market is segmented as follows-

By Product Type:

  • First-generation epilepsy therapeutics
  • Second-generation epilepsy therapeutics
  • Third-generation epilepsy therapeutics

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Epilepsy Therapeutic Market, By Product Type, Estimates and Forecast, 2014-2023($Million)
  • First-generation epilepsy therapeutics
  • Second-generation epilepsy therapeutics
  • Third-generation epilepsy therapeutics
  • Epilepsy Therapeutic Market, By Region, Estimates and Forecast, 2014-2023($Million)
    • North America
  • North America Epilepsy Therapeutic Market, By Country
  • North America Epilepsy Therapeutic Market, By Product Type
    • U.S. Epilepsy Therapeutic Market, By Product Type
    • Canada Epilepsy Therapeutic Market, By Product Type
    • Mexico Epilepsy Therapeutic Market, By Product Type
    • Europe
  • Europe Epilepsy Therapeutic Market, By Country
  • Europe Epilepsy Therapeutic Market, By Product Type
    • Germany Epilepsy Therapeutic Market, By Product Type
    • France Epilepsy Therapeutic Market, By Product Type
    • UK Epilepsy Therapeutic Market, By Product Type
    • Italy Epilepsy Therapeutic Market, By Product Type
    • Spain Epilepsy Therapeutic Market, By Product Type
    • Rest of Europe Epilepsy Therapeutic Market, By Product Type
    • Asia-Pacific
      • Asia-Pacific Epilepsy Therapeutic Market, By Country
      • Asia-Pacific Epilepsy Therapeutic Market, By Product Type
        • Japan Epilepsy Therapeutic Market, By Product Type
        • Australia Epilepsy Therapeutic Market, By Product Type
        • India Epilepsy Therapeutic Market, By Product Type
        • South Korea Epilepsy Therapeutic Market, By Product Type
        • Rest of Asia-Pacific Epilepsy Therapeutic Market, By Product Type
    • Rest of the World
      • Rest of the World Epilepsy Therapeutic Market, By Country
      • Rest of the World Epilepsy Therapeutic Market, By Product Type
        • Brazil Epilepsy Therapeutic Market, By Product Type
        • South Africa Epilepsy Therapeutic Market, By Product Type
        • Saudi Arabia Epilepsy Therapeutic Market, By Product Type
        • Turkey Epilepsy Therapeutic Market, By Product Type
        • United Arab Emirates Epilepsy Therapeutic Market, By Product Type
        • Others Epilepsy Therapeutic Market, By Product Type

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Rising Demand in End-User Industries

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Epilepsy Therapeutic Market, By Product Type

4.1.       Introduction

4.2.       Global Epilepsy Therapeutic Sales, Revenue and Market Share by Product Type (2017-2017)

4.2.1.  Global Epilepsy Therapeutic Sales and Sales Share by Product Type (2017-2017)

4.2.2.  Global Epilepsy Therapeutic Revenue and Revenue Share by Product Type (2017-2017)

4.3.       Epilepsy Therapeutic Market Assessment and Forecast, By Product Type, 2017-2023

4.4.       First-Generation Epilepsy Therapeutics

4.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

4.5.       Second-Generation Epilepsy Therapeutics

4.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

4.6.       Third-Generation Epilepsy Therapeutics

4.6.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

5.       Epilepsy Therapeutic Market, By Region

5.1.       Introduction

5.2.       Epilepsy Therapeutic Market  Assessment and Forecast, By Region, 2017-2023($Million)

5.3.       Global Epilepsy Therapeutic Sales, Revenue and Market Share by Regions

5.3.1.  Global Epilepsy Therapeutic Sales by Regions (2017-2017)

5.3.2.  Global Epilepsy Therapeutic Revenue by Regions (2017-2017)

5.4.       North America

5.4.1.  North America Epilepsy Therapeutic Sales and Growth Rate (2017-2017)

5.4.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

5.4.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.4.4.  U.S.

5.4.4.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.4.5.  Canada

5.4.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.4.6.  Mexico

5.4.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.       Europe

5.5.1.  Europe Epilepsy Therapeutic Sales and Growth Rate (2017-2017)

 

5.5.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

5.5.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.4.  Germany

5.5.4.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.5.  France

5.5.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.6.  UK

5.5.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.7.  Italy

5.5.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.8.  Spain

5.5.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.5.9.  Rest of Europe

5.5.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.       Asia-Pacific

5.6.1.  Asia-Pacific Epilepsy Therapeutic Sales and Growth Rate (2017-2017)

5.6.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

5.6.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.4.  Japan

5.6.4.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.5.  China

5.6.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.6.  Australia

5.6.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.7.  India

5.6.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.8.  South Korea

5.6.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.6.9.  Rest of Asia-Pacific

5.6.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.       Rest of the World

5.7.1.  Rest of the World Epilepsy Therapeutic Sales and Growth Rate (2017-2017)

5.7.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

5.7.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.4.  Brazil

5.7.4.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.5.  Turkey

5.7.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.6.  Saudi Arabia

5.7.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.7.  South Africa

5.7.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.8.  United Arab Emirates

5.7.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

5.7.9.  Others

5.7.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.       Company Profiles

6.1.       Eisai

6.1.1.  Business Overview

6.1.2.  Product Portfolio

6.1.3.  Strategic Developments

6.1.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

6.2.        GlaxoSmithKline

6.2.1.  Business Overview

6.2.2.  Product Portfolio

6.2.3.  Strategic Developments

6.2.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

6.3.       Pfizer

6.3.1.  Business Overview

6.3.2.  Product Portfolio

6.3.3.  Strategic Developments

6.3.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

6.4.       UCB

6.4.1.  Business Overview

6.4.2.  Product Portfolio

6.4.3.  Strategic Developments

6.4.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

6.5.       Dainippon Sumitomo Pharma

6.5.1.  Business Overview

6.5.2.  Product Portfolio

6.5.3.  Strategic Developments

6.5.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

6.6.       Janssen Pharmaceutical

6.6.1.  Business Overview

6.6.2.  Product Portfolio

6.6.3.  Strategic Developments

6.6.4.  Epilepsy Therapeutic Sales, Revenue and Market Share

7.       Global Epilepsy Therapeutic Market Competition, by Manufacturer

7.1.       Global Epilepsy Therapeutic Sales and Market Share by Manufacturer (2017-2017)

7.2.       Global Epilepsy Therapeutic Revenue and Market Share by Manufacturer (2017-2017)

7.3.       Top 5 Epilepsy Therapeutic Manufacturer Market Share

7.4.       Market Competition Trend


List of Tables

You can glance through the list of Tables and Figures when you view the sample copy of Epilepsy Therapeutic Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*